Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.645 -0.005 (-0.30%)
Streaming Delayed Price Updated: 3:02 PM EDT, Aug 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 956,984
Open 1.620
Bid (Size) 1.640 (42)
Ask (Size) 1.650 (317)
Prev. Close 1.650
Today's Range 1.600 - 1.690
52wk Range 1.110 - 5.970
Shares Outstanding 397,347,051
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amarin Corp Earnings Perspective: Return On Capital Employed
  
Via Benzinga
Does Amarin Deserve a Spot in Your Portfolio after Earnings ?
Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio. 
Via MarketBeat
Topics Earnings
Exposures Financial

Performance

YTD
-53.13%
-53.13%
1 Month
+21.85%
+21.85%
3 Month
+9.67%
+9.67%
6 Month
-51.62%
-51.62%
1 Year
-68.90%
-68.90%

More News

Read More
Amarin Still Suspends FY22 Guidance On Generic Challenges
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Via Benzinga
Amarin Corp: Q2 Earnings Insights
Via Benzinga
Amarin Outlines $100M Cost Saving Plan
Via Benzinga
Recap: Amarin Corp Q1 Earnings
Via Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
Via Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting
From Sarissa Capital Management LP
Via Business Wire
Looking Into Amarin Corp's Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022
Via Benzinga
A Peek Into The Markets: US Stock Futures Down; Jobs Report In Focus
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022
Via Benzinga
10 Biggest Price Target Changes For Thursday
Via Benzinga
81 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Amarin Corp's Earnings: A Preview
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.